InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Anixa Biosciences Inc

ANIX Clue Score34
United States Fiscal year ends October CIK 0000715446
$2.90 -0.34% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.90 −34.39% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.3Operating income−4.5Net income−5.0Fiscal year 2017Revenue0.4 +20.8%Operating income−6.1Net income−5.0Fiscal year 2018Revenue1.1 +206.9%Operating income−14.3Net income−14.0Fiscal year 2019Revenue0.3 −77.5%Operating income−11.9Net income−11.6Fiscal year 2020Operating income−10.0Net income−10.0Fiscal year 2021Revenue0.5Operating income−13.1Net income−13.0Fiscal year 2022Operating income−13.9Net income−13.6EPS, diluted0.45Fiscal year 2023Revenue0.2Operating income−11.0Net income−9.8EPS, diluted−0.32Fiscal year 2024Revenue0.2 +0.0%Operating income−13.8Net income−12.6EPS, diluted−0.39Fiscal year 2025Operating income−11.7Net income−10.9EPS, diluted−0.34
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.3 0.4 1.1 0.3 n/a 0.5 n/a 0.2 0.2 n/a
Growth +20.8% +206.9% −77.5% +0.0%
Operating income −4.5 −6.1 −14.3 −11.9 −10.0 −13.1 −13.9 −11.0 −13.8 −11.7
Net income −5.0 −5.0 −14.0 −11.6 −10.0 −13.0 −13.6 −9.8 −12.6 −10.9
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a 0.45 −0.32 −0.39 −0.34

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,503.0%Net margin−1,672.1%Free cash flow margin−1,176.1%Fiscal year 2017Operating margin−1,676.0%Net margin−1,381.8%Free cash flow margin−1,055.7%Fiscal year 2018Operating margin−1,284.4%Net margin−1,258.1%Free cash flow margin−387.6%Fiscal year 2019Operating margin−4,756.0%Net margin−4,658.8%Free cash flow margin−1,966.8%Fiscal year 2020Fiscal year 2021Operating margin−2,565.6%Net margin−2,530.1%Fiscal year 2022Fiscal year 2023Operating margin−5,243.3%Net margin−4,671.9%Fiscal year 2024Operating margin−6,586.2%Net margin−5,978.1%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,503.0% −1,676.0% −1,284.4% −4,756.0% n/a −2,565.6% n/a −5,243.3% −6,586.2% n/a
Net margin −1,672.1% −1,381.8% −1,258.1% −4,658.8% n/a −2,530.1% n/a −4,671.9% −5,978.1% n/a
Free cash flow margin −1,176.1% −1,055.7% −387.6% −1,966.8% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−3.4Capital expenditure−0.1Free cash flow−3.5Fiscal year 2017Operating cash flow−3.8Capital expenditure−0.0Free cash flow−3.8Fiscal year 2018Operating cash flow−4.3Capital expenditure−0.0Free cash flow−4.3Fiscal year 2019Operating cash flow−4.7Capital expenditure−0.2Free cash flow−4.9Fiscal year 2020Operating cash flow−6.2Capital expenditure−0.0Free cash flow−6.2Fiscal year 2021Operating cash flow−4.9Fiscal year 2022Operating cash flow−6.5Fiscal year 2023Operating cash flow−6.2Fiscal year 2024Operating cash flow−7.3Buybacks−0.0Fiscal year 2025Operating cash flow−7.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −3.4 −3.8 −4.3 −4.7 −6.2 −4.9 −6.5 −6.2 −7.3 −7.2
Capital expenditure −0.1 −0.0 −0.0 −0.2 −0.0 n/a n/a n/a n/a n/a
Free cash flow −3.5 −3.8 −4.3 −4.9 −6.2 n/a n/a n/a n/a n/a
Growth
Buybacks n/a n/a n/a n/a n/a n/a n/a n/a −0.0 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash2.5Shareholders’ equity1.0Fiscal year 2017Cash3.3Shareholders’ equity7.9Fiscal year 2018Cash3.1Shareholders’ equity5.4Fiscal year 2019Cash3.5Shareholders’ equity5.2Fiscal year 2020Cash6.4Shareholders’ equity8.8Fiscal year 2021Cash29.1Shareholders’ equity35.4Fiscal year 2022Cash12.4Shareholders’ equity29.0Fiscal year 2023Cash0.9Shareholders’ equity24.3Fiscal year 2024Cash1.3Shareholders’ equity20.0Fiscal year 2025Cash1.2Shareholders’ equity15.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.5 3.3 3.1 3.5 6.4 29.1 12.4 0.9 1.3 1.2
Shareholders’ equity 1.0 7.9 5.4 5.2 8.8 35.4 29.0 24.3 20.0 15.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending October, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Oct 2016 FY2017 31 Oct 2017 FY2018 31 Oct 2018 FY2019 31 Oct 2019 FY2020 31 Oct 2020 FY2021 31 Oct 2021 FY2022† 31 Oct 2022 FY2023 31 Oct 2023 FY2024 31 Oct 2024 FY2025 31 Oct 2025
Revenue and profit
0.3 0.4 1.1 0.3 n/a 0.5 n/a 0.2 0.2 n/a
Growth +20.8% +206.9% −77.5% +0.0%
1.6 1.6 6.8 5.5 4.4 6.2 6.7 4.8 6.4 5.1
2.7 4.4 6.9 5.7 5.6 7.1 7.2 6.3 7.4 6.6
−4.5 −6.1 −14.3 −11.9 −10.0 −13.1 −13.9 −11.0 −13.8 −11.7
Growth
−5.0 −5.0 −14.2 −11.8 n/a n/a n/a n/a n/a n/a
−5.0 −5.0 −14.0 −11.6 −10.0 −13.0 −13.6 −9.8 −12.6 −10.9
Growth
Per share
n/a n/a n/a n/a n/a −0.45 0.45 −0.32 −0.39 −0.34
n/a n/a n/a n/a n/a n/a 0.45 −0.32 −0.39 −0.34
Growth −171.1%
n/a n/a n/a n/a n/a n/a 0.0 0.0 0.0 0.0
n/a n/a n/a n/a n/a 28.6 0.0 0.0 0.0 0.0
Growth −99.9% +2.0% +3.0% +1.7%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 10.3% a year over five years.
  • Operating margin is down 4,910.2 points on five years ago, at -6,586.2%.
  • A net loss in 10 of 10 years on file.